A Google patent application, US 2024/0077933 A1, details methods for acarbose biosynthesis. The application claims a process for producing acarbose using microorganisms. Specific claims relate to genetically modified microbial strains, fermentation conditions, and purification steps involved in acarbose synthesis [1].
What are the key claims in Google's acarbose biosynthesis patent application?
The patent application outlines several key claims focused on the engineered microbial production of acarbose. These include specific genetic modifications to microorganisms to enhance acarbose production [1]. Additionally, the claims cover the fermentation media composition and process parameters, such as temperature, pH, and aeration, that are optimized for efficient biosynthesis [1]. The application also claims methods for isolating and purifying acarbose from the fermentation broth [1].
How do these methods differ from traditional acarbose production?
Traditional acarbose production relies on extraction from natural sources, primarily from the bacterium Actinoplanes utahensis. Google's patented approach shifts this to a synthetic biology method, engineering different microorganisms to produce acarbose through fermentation. This microbial biosynthesis method aims for greater control over the production process and potentially higher yields and purity compared to extraction [1].
What are the potential advantages of microbial biosynthesis for acarbose?
Microbial biosynthesis offers several potential advantages. It can allow for more sustainable and scalable production by utilizing engineered microorganisms. This method can also lead to a more consistent product quality and potentially reduce the environmental impact associated with traditional extraction methods [1]. Furthermore, it offers flexibility in optimizing production through genetic engineering and fermentation control.
What is acarbose and what is it used for?
Acarbose is an oral alpha-glucosidase inhibitor. It is used to treat type 2 diabetes mellitus by slowing down the digestion of carbohydrates in the digestive tract. This leads to a reduction in postprandial (after-meal) blood glucose levels [2].
Who else is involved in acarbose production and patents?
While Google's patent application focuses on a novel biosynthesis method, acarbose itself has been a subject of patents and production by various pharmaceutical companies. Historically, Bayer AG was a key developer and marketer of acarbose under brand names like Glucobay and Precose [3]. Companies involved in generic drug manufacturing may also hold patents related to acarbose formulations or production processes. Information on existing acarbose patents and their expiry can be found on resources like DrugPatentWatch.com [4].